{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:32:20Z","timestamp":1776123140858,"version":"3.50.1"},"reference-count":14,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,2,15]]},"abstract":"<jats:p>Percutaneous minimally invasive radiofrequency (RF) ablation has not been described for lymphoma. This image-guided modality is presented in 3 different settings for the treatment of refractory lymphoma. The first patient received RF ablation for the curative treatment of a solitary residual hepatic mass following rituximab-based chemotherapy for a posttransplantation lymphoproliferative disorder (PTLD) and is disease-free 4 years later. The second patient received RF ablation for successful palliation of progressive follicular lymphoma adjacent to the bladder wall following chemotherapy and maximum radiation. The third patient received RF ablation for prevention of airway obstruction from progressive diffuse large B-cell lymphoma of the right neck following chemotherapy and maximum radiation. RF ablation may be clinically beneficial and should be considered for the treatment of local lymphoma that is refractory or not amenable to standard approaches.<\/jats:p>","DOI":"10.1182\/blood-2005-05-2131","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T00:40:45Z","timestamp":1130460045000},"page":"1624-1626","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Radiofrequency ablation of lymphoma"],"prefix":"10.1182","volume":"107","author":[{"given":"Deepak","family":"Sudheendra","sequence":"first","affiliation":[{"name":"From the Department of Radiology, National Institutes of Health, Bethesda, MD; Department of Radiology, Beth Israel Deaconness Medical Center, Boston, MA; Department of Hematology, University of Connecticut Health Center, Farmington; and Medicine Branch, National Cancer Institute, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara M.","family":"Barth","sequence":"additional","affiliation":[{"name":"From the Department of Radiology, National Institutes of Health, Bethesda, MD; Department of Radiology, Beth Israel Deaconness Medical Center, Boston, MA; Department of Hematology, University of Connecticut Health Center, Farmington; and Medicine Branch, National Cancer Institute, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upendra","family":"Hegde","sequence":"additional","affiliation":[{"name":"From the Department of Radiology, National Institutes of Health, Bethesda, MD; Department of Radiology, Beth Israel Deaconness Medical Center, Boston, MA; Department of Hematology, University of Connecticut Health Center, Farmington; and Medicine Branch, National Cancer Institute, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wyndham H.","family":"Wilson","sequence":"additional","affiliation":[{"name":"From the Department of Radiology, National Institutes of Health, Bethesda, MD; Department of Radiology, Beth Israel Deaconness Medical Center, Boston, MA; Department of Hematology, University of Connecticut Health Center, Farmington; and Medicine Branch, National Cancer Institute, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford J.","family":"Wood","sequence":"additional","affiliation":[{"name":"From the Department of Radiology, National Institutes of Health, Bethesda, MD; Department of Radiology, Beth Israel Deaconness Medical Center, Boston, MA; Department of Hematology, University of Connecticut Health Center, Farmington; and Medicine Branch, National Cancer Institute, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020071613413840300_REF1","doi-asserted-by":"crossref","unstructured":"Goldberg SN. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound. 2002;13: 129-147.","DOI":"10.1016\/S0929-8266(01)00126-4"},{"key":"2020071613413840300_REF2","doi-asserted-by":"crossref","unstructured":"Neeman Z, Wood B. Radiofrequency ablation beyond the liver. Tech Vasc Interv Radiol. 2002;5: 156-163.","DOI":"10.1053\/tvir.2002.36419"},{"key":"2020071613413840300_REF3","doi-asserted-by":"crossref","unstructured":"Gadaleta C, Catino A, Ranieri G, et al. Radiofrequency thermal ablation of 69 lung neoplasms. J Chemother. 2004;16(suppl 5): 86-89.","DOI":"10.1080\/1120009X.2004.11782394"},{"key":"2020071613413840300_REF4","doi-asserted-by":"crossref","unstructured":"Wilson WH, Gutierrez M, O'Connor P, et al. The role of rituximab and chemotherapy in aggressive B-cell lymphoma; a preliminary report of dose-adjusted EPOCH-R. Semin Oncol. 2002; 29: 41-47.","DOI":"10.1053\/sonc.2002.30151"},{"key":"2020071613413840300_REF5","doi-asserted-by":"crossref","unstructured":"Wilson WH, Grossbard ML, Pittaluga S, et al. Dose-adjusted EPOCH chemotherapy for untreated B-cell lymphomas: a pharmacodynamic approach with high efficacy. Blood. 2002;99: 2685-2693.","DOI":"10.1182\/blood.V99.8.2685"},{"key":"2020071613413840300_REF6","doi-asserted-by":"crossref","unstructured":"Kewalramani T, Zelenetz AD, Nimer SD. Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary diffuse large B-cell lymphoma. Blood. 2004;103: 3684-3688.","DOI":"10.1182\/blood-2003-11-3911"},{"key":"2020071613413840300_REF7","doi-asserted-by":"crossref","unstructured":"Bishop MR, Hou JW, Wilson WH, et al. Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas. Biol Blood Marrow Transplant. 2003;9: 162-169.","DOI":"10.1016\/S1083-8791(03)70005-6"},{"key":"2020071613413840300_REF8","doi-asserted-by":"crossref","unstructured":"Ahmed M, Goldberg SN. Combination radiofrequency ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia. 2004;20: 781-802.","DOI":"10.1080\/02656730410001711655"},{"key":"2020071613413840300_REF9","unstructured":"Sparks RB, Crowe EA, Wong FC, Toohey RE, Siegel JA. Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity. J Nucl Med. 2002; 43: 1110-1114."},{"key":"2020071613413840300_REF10","doi-asserted-by":"crossref","unstructured":"Dodd GD, Napier D, Schoolfield, JD, Hubbard L. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol. 2005;185: 51-57.","DOI":"10.2214\/ajr.185.1.01850051"},{"key":"2020071613413840300_REF11","doi-asserted-by":"crossref","unstructured":"Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol. 2005;14: 41-52.","DOI":"10.1016\/j.suronc.2005.01.001"},{"key":"2020071613413840300_REF12","doi-asserted-by":"crossref","unstructured":"den Brok MH, Sutmuller RP, van der Voort R, et al. In-situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res. 2004;64: 4024-4029.","DOI":"10.1158\/0008-5472.CAN-03-3949"},{"key":"2020071613413840300_REF13","doi-asserted-by":"crossref","unstructured":"Hansler J, Neureiter D, Wasserburger M, et al. Percutaneous US-guided radiofrequency ablation with perfused needle applicators: improved survival with the VX2 tumor model in rabbits. Radiology. 2004;230: 169-174.","DOI":"10.1148\/radiol.2301021136"},{"key":"2020071613413840300_REF14","unstructured":"Wissniowski TT, Hunsler J, Neureiter D, et al. Activation of tumor-specific T lymphomcytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res. 2003;63: 6496-6500."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/4\/1624\/469304\/zh800406001624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/4\/1624\/469304\/zh800406001624.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:25:21Z","timestamp":1594945521000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/4\/1624\/133716\/Radiofrequency-ablation-of-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,15]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-05-2131","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,15]]}}}